To explore the pathway by which L-fucose acts on CD4+ T cells and LPMCs, we found that the mRNA levels of AHR and its target gene, CYP1A1, were significantly elevated in the colons of colitis mice by L-fucose treatment. The gene discussed is CYP1A1; the disease is colitis.